Frontlight ResearchEarly access
Not yet recruitingNo phase
Comparing the Efficacy of a Conversational Agent (QuitBot) Versus Standard Health Education on Smoking Cessation Among Medical Students in Cairo University
Key facts
- Who runs it
- Cairo University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 180 people, planned
- Starts
- 10 Dec 2026
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Conversational agent
- Standard health education
- Record updated
- 2 November 2026
Who can take part
- Age
- 19 years to 24 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Enrolled adult medical student at Cairo University with age range (19 - 25) years old. The age range will be from 19 years old to fulfill WHO definition of adulthood
- Current smoker (defined as smoking at least one cigarette- cigarette or vaping per day in the past month)
- Motivated to quit smoking within the next six months
- Able to communicate in English sufficiently to use the chatbot
- Has access to a smartphone with internet connection
- Provides informed consent to participate
Who cannot take part
- Students with known severe psychiatric illness or cognitive impairment that may interfere with chatbot interaction identified by self-report
- Students currently enrolled in another smoking cessation program or using pharmacological cessation aids
- Students unable or unwilling to provide consent
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 19 and 24 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Comparing the efficacy of conversational agent and standard health education in promoting smoking cessation among medical students in Cairo university
The 2 groups in the trial
- conversational agent armTreatment being tested
Participants are medical students who smoke, and will receive smoking cessation intervention through an AI conversational chatbot.
Treatment: Conversational agent
- Standard health educationExisting treatment, for comparison
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Comparing the Efficacy of a Conversational Agent (QuitBot) Versus Standard Health Education on Smoking Cessation Among Medical Students; A Randomized Controlled Trial.
- Criteria questions
- Built from NCT07906249, who can take part
- Record updated
- 2 November 2026